Functional studies using BM chimeras revealed that hematopoietic deletion of Ccl2 significantly reduced both tumor burden and the presence of extravascular recMacs, demonstrating that macrophage-intrinsic CCL2 promotes tumor progression. Here, CCL2 is linked to neoplasm.